BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16951769)

  • 1. Carrier screening and prenatal detection of chronic granulomatous disease in Iran.
    Ayatollahi M; Geramizadeh B
    Saudi Med J; 2006 Sep; 27(9):1334-7. PubMed ID: 16951769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fast and easy nitroblue tetrazolium method for carrier screening and prenatal detection of chronic granulomatous disease.
    Ayatollahi M; Tabei Z; Ramzi M; Kashef S; Haghshenas M
    Arch Iran Med; 2006 Oct; 9(4):335-8. PubMed ID: 17061605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitroblue tetrazolium slide test. Use of the phorbol-myristate-acetate-stimulated NBT-reduction slide test for routine and prenatal detection of chronic granulomatous disease and diagnosis of heterozygous carriers.
    Johansen KS
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):349-54. PubMed ID: 6673503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phorbol myristate acetate stimulated NBT test: a simple method suitable for antenatal diagnosis of chronic granulomatous disease.
    Levinsky RJ; Harvey BA; Rodeck CH; Soothill JF
    Clin Exp Immunol; 1983 Nov; 54(2):595-8. PubMed ID: 6360441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil function screening in patients with chronic granulomatous disease by a flow cytometric method.
    Epling CL; Stites DP; McHugh TM; Chong HO; Blackwood LL; Wara DW
    Cytometry; 1992; 13(6):615-20. PubMed ID: 1451593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis of chronic granulomatous disease.
    Matthay KK; Golbus MS; Wara DW; Mentzer WC
    Am J Med Genet; 1984 Apr; 17(4):731-9. PubMed ID: 6720741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exclusion prenatal diagnosis of chronic familial septic granulomatosis].
    Pham Huu T; Dumez Y; Durand A; Le Merrer M; Lemerle-Gruson S; Hakim J; Griscelli C
    Arch Fr Pediatr; 1985 Feb; 42(2):103-5. PubMed ID: 4004464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions.
    Emmendörffer A; Nakamura M; Rothe G; Spiekermann K; Lohmann-Matthes ML; Roesler J
    Cytometry; 1994 Sep; 18(3):147-55. PubMed ID: 7813334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staining of eosinophils with nitroblue tetrazolium in patients with chronic granulomatous disease.
    Roberts RL; Ohno Y; Gallin JI
    Pediatr Res; 1986 Apr; 20(4):378-80. PubMed ID: 2422626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of nitroblue tetrazolium (NBT) test.
    Parvaneh N; Teimourian S
    Arch Iran Med; 2008 Jan; 11(1):129-30; author reply 130. PubMed ID: 18389564
    [No Abstract]   [Full Text] [Related]  

  • 11. Prenatal diagnosis of chronic granulomatous disease in a male fetus.
    Yavuz Köker M; Metin A; Ozgür TT; de Boer M; Roos D
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):57-61. PubMed ID: 19279361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and carrier detection of chronic granulomatous disease in five families by flow cytometry.
    Crockard AD; Thompson JM; Boyd NA; Haughton DJ; McCluskey DR; Turner CP
    Int Arch Allergy Immunol; 1997 Oct; 114(2):144-52. PubMed ID: 9338608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical course and pathomechanisms of chronic granulomatosis].
    Czarnetzki BM; Happle R; Belcher RW
    Hautarzt; 1984 Apr; 35(4):175-81. PubMed ID: 6724905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic granulomatous disease. Expression of the metabolic defect by in vitro culture of bone marrow progenitors.
    Newburger PE; Kruskall MS; Rappeport JM; Robinson SH; Chovaniec ME; Cohen HJ
    J Clin Invest; 1980 Sep; 66(3):599-602. PubMed ID: 6249853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of carriers of the autosomal form of chronic granulomatous disease.
    Verhoeven AJ; van Schaik ML; Roos D; Weening RS
    Blood; 1988 Feb; 71(2):505-7. PubMed ID: 3337910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric evaluation of nitro blue tetrazolium (NBT) reduction in human polymorphonuclear leukocytes.
    Fattorossi A; Nisini R; Le Moli S; De Petrillo G; D'Amelio R
    Cytometry; 1990; 11(8):907-12. PubMed ID: 2272251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved nitroblue tetrazolium test using phorbol myristate acetate-coated coverslips.
    Repine JE; Rasmussen B; White JG
    Am J Clin Pathol; 1979 May; 71(5):582-5. PubMed ID: 453076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discoid lupus erythematosus and carrier status of X-linked chronic granulomatous disease.
    Lindskov R; Munkvad JM; Valerius NH
    Dermatologica; 1983; 167(5):231-3. PubMed ID: 6653847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of phorbol myristate acetate on the metabolism of neutrophils from carriers of sex-linked chronic granulomatous disease.
    Repine JE; White JG; Clawson CC; Holmes BH
    J Lab Clin Med; 1975 Jan; 85(1):82-6. PubMed ID: 1141733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis of chronic granulomatous disease.
    Newburger PE; Cohen HJ; Rothchild SB; Hobbins JC; Malawista SE; Mahoney MJ
    N Engl J Med; 1979 Jan; 300(4):178-81. PubMed ID: 83536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.